200 investor emails, zero replies: a pre-seed founder's problem is the list, not the pitch
MartinGTobias · x · 2026-10-24
A healthtech pre-seed founder posted about sending 200+ investor emails with no replies. The author argues that's a list problem, not an investor problem: of 200 generic emails, maybe 15 investors fund healthtech at pre-seed at all — the other 185 were never going to reply.
Better: 20 investors who actually write healthtech pre-seed checks, with a tailored line for each. Fundability isn't the bottleneck; targeting is.
More from Venture
- $16.3B revenue, $80.7B net loss — and a $2T IPO valuation — gaganghotra_ · 2026-10-24
- a16z charts: US media consumption plateaus at ~25 hrs/week as YouTube and social eat everything else — a16z · 2026-10-24
- Indie dev ships three Windows apps built with Claude Code to Microsoft Store — raudlaur · 2026-10-24
- Zack Kanter: cold B2B outbound gets more effective as agents take over inboxes and hunt for solutions to buy — MartinGTobias · 2026-10-24
- A $370K Series C offer is really $270K a year once sign-on and equity are amortized — aakashgupta · 2026-10-24
- Industrial AI startup raises $130M Series D at $1.4B valuation led by Sapphire Ventures — ycombinator · 2026-10-24